Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Potential biomarker discovered for brain tumors in children

researcher in lab © Medical University of Vienna/Houdek

This was shown by a study conducted at the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital within the framework of the Comprehensive Cancer Center (CCC) and in collaboration with the German Cancer Research Center in Heidelberg.

The new study by Johannes Gojo, junior doctor and researcher at the Department of Pediatrics and Adolescent Medicine of MedUni Vienna and Vienna General Hospital and member of the CCC, investigated whether the enzyme telomerase could be used as a biomarker for ependymomas. Gojo states: "We were able to show that telomerase was primarily reactivated in tumors that exhibit a particularly aggressive course. This means that the tumor recurred despite surgical removal and subsequent radiotherapy and chemotherapy." The scientists suspect that this will enable them to identify patients who would benefit from more intensive treatment. Conversely, patients with less aggressive tumors could be spared chemotherapy. This would mean a huge improvement in the quality of life for those affected. "Together with other parameters, the presence of telomerase could be a big help in deciding on the course of treatment. It therefore represents a highly promising biomarker.” The study was published in the leading scientific journal Nero-Oncology.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Research and Found Your Company in Austria

    29.01.2020 / 16:30 - 18:00, Zurich, Switzerland

  • New Year's Reception

    29.01.2020 / 18:00, Zurich, Switzerland

Austria Map

Find the perfect location for your company

Thanks to a fantastic mindset, our employees at the Villach site have built up a unique expertise which helps us to further strengthen our position on the global market. We fuse high-performance manufacturing with research and development in the field of power electronics. In addition to a very good cooperation with partners and networks, a well-developed landscape of 'talent factories' ranging from higher technical colleges to universities, we as a company also value the outstanding model of research promotion which exists in Austria.

Infineon

Logo Infineon
More testimonials

news from the business location Austria

Russian startup Bobsla ventures into the Austrian market and is developing a “miniature snow drifter” for brave winter tourists

In addition to conventional skiing and snowboarding, tourists in the Ötztal Valley in Austria can also spend their time enjoying a further attraction. Bobsla is a vehicle which looks like a fusion of a snow plough and a go-cart. It is steered by its guests and operated on snow surfaces.

The new research allowance in Germany – in competition with the Austrian research tax credit?

Companies carrying out research and development in Austria have the possibility to apply for research funding, namely the so-called research tax credit. In an international comparison, the Austrian research tax credit is a recipe for success and is designed to showcase and enhance the attractiveness of Austria as a research location. The successive increase in the research tax credit from the original level of three percent in 2002 to 14 percent at present has made a massive contribution to this success.

More news All blog posts